肝转移癌,Hepatic metastasis
1)Hepatic metastasis肝转移癌
1.Radical Operation of Colorectal Carcinoma Plus Radiofrequency Ablation for Hepatic Metastasis at Same Stage;一期结直肠癌切除与射频消融治疗肝转移癌
英文短句/例句
1.The Study of the Phenomenon That Cirrhosis Liver is Resisitant to the Metastasis and It s Mechanisms;肝硬化抑制肝转移癌形成及其作用机制的研究
2.The imageology diagnosis on recurrence and metastasis of primary liver cancer after liver transplantation肝癌肝移植术后复发转移的影像诊断
3.Relationship between Expression of SDF-1 in Liver and Metastasis of Colorectal Carcinoma肝脏SDF-1表达与结直肠癌肝转移
4.Differential diagnosis of isolated hepatocellular carcinoma and metastatic hepatic carcinoma with contrast-enhanced ultrasonography超声造影鉴别诊断肝细胞癌与单发转移性肝癌
5.Re-resection of extrahepatic metastatic primary liver carcinoma原发性肝癌肝外转移癌六例再切除体会
6.The biliary obstruction was caused by hepatoma 21 cases: liver portal lymph node metastasis with stomach cancer 8 cases, biliary carcinoma 6 and pancreatic cancer 6 cases .胃癌肝门淋巴结转移8例、肝癌21例、胆管癌6例、胰头癌6例。
7.Optimization of a Metastatic Cell Model of Human Hepatocellular Carcinoma and Study on the Mechanisms of Metastasis;转移性人肝癌细胞模型的优化及转移机理探讨
8.The Molecular Mechanism of Metastasis Inhibition by TIP30/CC3 in Human Hepatocellular Carcinoma;TIP30/CC3抑制肝癌转移的分子机制研究
9.Role of the Novel Gene BNIPL Involved in the Growth and Metastasis of Human Hepatocellular Carcinoma Cells;新基因BNIPL在肝癌生长和转移中的作用
10.The Study on Relationship between RhoA Gene Expression and Invasion and Metastasis in Hepatocellular Carcinoma;RhoA表达与肝癌侵袭转移的相关性研究
11.Micrometastasis of Primary Liver Cancer and Defining of Its Resection Margin;原发性肝癌的微转移及其切缘的确定
12.The Influence of RhoC Gene on Invasion and Metastasis of Hepatocellular Carcinoma;RhoC基因对肝癌侵袭转移的影响
13.To Study the Anticancer Metastasis Compound s Mechanism of Anti-transplanted Hep-liver Cancer of Mice;抗肿瘤转移方抗HEP肝癌作用机制研究
14.The Molecular Mechanism of 67LR Promoting the Invasion and Metastasis of HCC;67LR促进肝癌侵袭转移的分子机制研究
15.Study on Suppression of Programmed Cell Death 4 (PDCD4) to Metastastic Potential of Human Hepatocellular Carcinoma CellsPDCD4抑制人肝癌细胞转移潜能的研究
16.Correlation of CXCR4,VHL and NFκB Status with Colorectal Cancer MetastasisVHL、NFκB和CXCR4状态与结肠癌肝转移的关系
17.Treatment of TACE Combined with PEIT for Metastatic Liver CancerTACE联合PEIT治疗转移性肝癌
18.Advanced Research on Molecular Mechanisms of Hepatic Metastasis in Colorectal Cancer结直肠癌肝转移的分子机制研究进展
相关短句/例句
liver metastases肝转移癌
1.Objective To observe the performance ofliver metastases with contrast-enhanced ultrasound(CEUS) and assess its clinical application.目的观察肝转移癌超声造影表现并探讨其临床应用价值。
2.Objective To observe the effects of percutaneous ethanol injection therapy (PEIT) for advancedliver metastases and to explore the dose of ethanol.目的观察无水酒精瘤内注射治疗肝转移癌的疗效 ,并探讨无水酒精的用量。
3.Objective:To evaluate the feasibility and toxicity,and estimate the therapeutic effect of patients with unresectableliver metastases from colorectal carcinoma treated with three-dimensional conformal radiation therapy after TACE.结论:对于结直肠癌根治术后出现不宜或不能手术的肝转移癌,应用三维适形放疗结合TACE的治疗模式,是可行的,无严重不良反应,近期疗效显著。
3)Hepatic metastases肝转移癌
4)Metastatic liver cancer肝转移癌
1.Value of serum CEA,SF and AFP determination in diagnosis of metastatic liver cancer;血清CEA、SF、AFP联合检测对肝转移癌的诊断价值
5)metastatic hepatocelluar carcinoma肝癌转移
1.Objective:To explore the effective methods of establishing a humanmetastatic hepatocelluar carcinoma model in human peripheral blood lymphocyte (hu-PBL) engrafted to severe combined immunodeficient (SCID) mice.结论:成功建立免疫重建荷人高转移肝癌SCID鼠模型,为肝癌转移的研究及治疗提供了理想的动物模型。
6)metastatic liver cancer转移性肝癌
1.Treatment ofmetastatic liver cancer with arterial perfusion of Chinese herbal drugs;中药动脉灌注治疗转移性肝癌的临床研究
2.Objective:To analysis the efficacy of diagnosis from imaging detection and tumor markers inmetastatic liver cancer originated from gastrointestinal tract.目的 :探讨影像学检查及来源于胃肠道的转移性肝癌其肿瘤标志物的检测对转移性肝癌的诊断价值。
3.Objectives: To observe effect of combined traditional Chinese medicine drugs (Konlate,Elemene,Huachansu,)administrated intra-arterially in treatment of patients withmetastatic liver cancer.目的:观察多种中药(康莱特、榄香烯、华蟾素)动脉灌注治疗转移性肝癌的疗效。
延伸阅读
正常人白细胞转移因子 , 白细胞转移因子,转移因子药物名称：转移因子英文名：Transfer Factor别名： 正常人白细胞转移因子 , 白细胞转移因子,转移因子外文名：Transfer Factor ,TF适应症： 为细胞免疫反应增强剂，能将细胞免疫活性转移给受体，以提高受体的免疫功能。临床上用于治疗某些抗生素难以控制的病毒性或酶菌性细胞内感染（如带状皰疹、流行性乙型脑炎、白色念珠菌感染等）。对恶性肿瘤可作为辅助治疗剂，对自体免疫性疾病也有一定治疗作用。 用量用法： 一般采用皮下注射，注于上臂内侧或大腿内侧腹股沟下端，１次注射１支，每周１～２次，１个月后改为每２周１次。对带状疱疹，一般只需注射１次。 规格： 注射液：每支２ｍｌ，相当于１×１０００００００００白细胞提取物（上海产）,北京产则相当于５～１０×1000000000. 注：严禁静脉给药.类别：免疫调节剂
